COVID-19 and Beyond: Oversight of the FDA’s Foreign Drug Manufacturing Inspection Process
For this hearing, the Senate Committee on Finance will follow guidelines developed in consultation with the Office of the Attending Physician (OAP), the Senate Sergeant at Arms, and the Senate Rules Committee to protect the health of Members, witnesses, staff and the public. This includes maintaining six-foot social distance spacing in the hearing room.
Pursuant to guidance from the CDC and OAP, Senate office buildings are not open to the public other than official business visitors and credentialed press at this time. Accordingly, in-person visitors cannot be accommodated at this hearing. We encourage the public to utilize the Committee’s livestream of the hearing, available on the website at http://www.finance.senate.gov.
All hearings are webcast live and will not be available until the hearing starts. Individuals with disabilities who require an auxiliary aid or service, including closed captioning service for webcast hearings, should contact the committee clerk at 202-224-4515 at least three business days in advance of the hearing date.
Questions about the feed or general questions about media attendance can be directed to: Michael_Zona@finance.senate.gov
Associate Commissioner for Regulatory Affairs, Office of Regulatory AffairsFood and Drug AdministrationSilver Spring , MD
Deputy Director for Regulatory Programs, Center for Drug Evaluation and ResearchFood and Drug AdministrationSilver Spring , MD
Associate Commissioner for Global Policy and StrategyFood and Drug AdministrationSilver Spring , MD
Director, Health CareUnited States Government Accountability OfficeWashington , DC
How do I submit a statement for the record?
Any individual or organization wanting to present their views for inclusion in the hearing record should submit a typewritten, single-spaced statement, not exceeding 10 pages in length. Title and date of the hearing, and the full name and address of the individual or organization must appear on the first page of the statement. Statements must be received no later than two weeks following the conclusion of the hearing.
Statements should be mailed (not faxed) to:
Senate Committee on Finance
Attn. Editorial and Document Section
Dirksen Senate Office Bldg.
Washington, DC 20510-6200